BACILLUS CALMETTE-GUERIN (BCG) THERAPY IS SAFE AND EFFECTIVE IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS WITH IMMUNOSUPPRESSIVE CONDITIONS

被引：0
|
作者：
Durant, Adri [1 ]
Choudry, Mouneeb [1 ]
Madura, Grace [1 ]
Mi Lanyu [1 ]
Tyson, Mark [1 ]
Faraj, Kassem [1 ]
机构：
[1] Univ Michigan, Mayo Clin Arizona, Ann Arbor, MI 48109 USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷
关键词：
D O I：
10.1016/j.urolonc.2024.01.174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
136
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [21] Bacillus Calmette-Guerin (BCG) and alternatives Drug treatment of high-risk non-muscle invasive bladder cancer
    Leucht, K.
    Foller, S.
    Grimm, Marc-Oliver
    UROLOGE, 2021, 60 (11): : 1400 - 1408
  • [22] The commensal urinary microbiome as a predictor of response to Bacillus Calmette-Guerin (BCG) immunotherapy in non-muscle invasive bladder cancer
    Sweis, Randy F.
    Golan, Shay
    Barashi, Nimrod
    Hill, Elle
    Andolfi, Ciro
    Werntz, Ryan
    Bloodworth, Jeffrey
    Gajewski, Thomas
    Steinberg, Gary D.
    CANCER RESEARCH, 2019, 79 (13)
  • [23] Effects of intravesical therapy with platelet-rich plasma (PRP) and Bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer
    Dias, Lara Paro
    Malheiros Luzo, Angela C.
    Volpe, Bruno B.
    Duran, Marcela
    Galdames, Sofia E. M.
    Ferreira, Luiz A. B.
    Duran, Nelson
    Favaro, Wagner J.
    TISSUE & CELL, 2018, 52 : 17 - 27
  • [24] A PROSPECTIVE COMPARATIVE STUDY OF INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) THERAPY WITH THE TOKYO OR CONNAUGHT STRAINS FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Sengiku, Atsushi
    Ito, Masaaki
    Miyazaki, Yu
    Sawazaki, Harutake
    Takahashi, Takeshi
    Ogura, Keiji
    JOURNAL OF UROLOGY, 2013, 189 (04): : E734 - E734
  • [25] Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer
    Obara, Wataru
    Hara, Isao
    Kato, Yoichiro
    Kato, Renpei
    Inoue, Keiji
    Sato, Fuminori
    Mimata, Hiromitsu
    Nakamura, Yusuke
    Fujioka, Tomoaki
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (09) : 1371 - 1380
  • [26] Clinical presentation of Bacille Calmette-Guerin (BCG) infections following BCG instillation therapy of non-muscle invasive Bladder Cancer
    Nurminen, P.
    Ettala, O.
    Uusitalo-Seppala, R.
    Kaipia, A.
    Bostrom, P. J.
    EUROPEAN UROLOGY, 2022, 81 : S256 - S257
  • [27] The Effectiveness of Bacillus Calmette-Guerin (BCG) Maintenance Treatment in Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
    Kim, B.
    Ha, J.
    Park, C.
    Kim, C.
    UROLOGY, 2012, 80 (03) : S215 - S216
  • [28] A study of intravesical bacillus Calmette-Guerin (BCG) in combination with ALT-803 in patients with non-muscle invasive bladder cancer.
    Rosser, Charles Joel
    Chamie, Karim
    Rock, Amy
    Ferguson, Lydia
    Wong, Hing C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [29] Pyuria as a Predictive Marker of Bacillus Calmette-Guerin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
    Suh, Jungyo
    Yuk, Hyeong Dong
    Jeong, Chang Wook
    Kwak, Cheol
    Kim, Hyeon Hoe
    Ku, Ja Hyeon
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [30] Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder Cancer: History and Current Status
    Liu, Gang
    Li, Bingheng
    Xu, Ziyang
    Wang, Jie
    Ma, Sai
    Kan, Yi
    Mao, Lijun
    DISCOVERY MEDICINE, 2022, 33 (169) : 85 - 92
12345